Development of a chaperone-mediated protein degrader targeting ERK5 that efficaciously reduces tumor growth.
Saved in:
| Title: | Development of a chaperone-mediated protein degrader targeting ERK5 that efficaciously reduces tumor growth. |
|---|---|
| Authors: | Yang X; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China., Yin W; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China., Xu M; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China., Tusa I; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, 50134, Italy., Menconi A; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, 50134, Italy., Dai Y; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China., Ding Q; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China., Wang G; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China., Foley KP; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China., Rovida E; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, 50134, Italy. elisabetta.rovida@unifi.it., Ying W; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China. wying@ranoktherapeutics.com. |
| Source: | Cell communication and signaling : CCS [Cell Commun Signal] 2026 Feb 03; Vol. 24 (1). Date of Electronic Publication: 2026 Feb 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X (Electronic) Linking ISSN: 1478811X NLM ISO Abbreviation: Cell Commun Signal Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41634806 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of a chaperone-mediated protein degrader targeting ERK5 that efficaciously reduces tumor growth. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yang+X%22">Yang X</searchLink>; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China.<br /><searchLink fieldCode="AU" term="%22Yin+W%22">Yin W</searchLink>; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China.<br /><searchLink fieldCode="AU" term="%22Xu+M%22">Xu M</searchLink>; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China.<br /><searchLink fieldCode="AU" term="%22Tusa+I%22">Tusa I</searchLink>; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, 50134, Italy.<br /><searchLink fieldCode="AU" term="%22Menconi+A%22">Menconi A</searchLink>; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, 50134, Italy.<br /><searchLink fieldCode="AU" term="%22Dai+Y%22">Dai Y</searchLink>; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China.<br /><searchLink fieldCode="AU" term="%22Ding+Q%22">Ding Q</searchLink>; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China.<br /><searchLink fieldCode="AU" term="%22Wang+G%22">Wang G</searchLink>; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China.<br /><searchLink fieldCode="AU" term="%22Foley+KP%22">Foley KP</searchLink>; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China.<br /><searchLink fieldCode="AU" term="%22Rovida+E%22">Rovida E</searchLink>; Department of Experimental and Clinical Biomedical Sciences 'Mario Serio', University of Florence, Florence, 50134, Italy. elisabetta.rovida@unifi.it.<br /><searchLink fieldCode="AU" term="%22Ying+W%22">Ying W</searchLink>; Ranok Therapeutics (Hangzhou), Inc, Hangzhou, Zhejiang, 310018, China. wying@ranoktherapeutics.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101170464%22">Cell communication and signaling : CCS</searchLink> [Cell Commun Signal] 2026 Feb 03; Vol. 24 (1). <i>Date of Electronic Publication: </i>2026 Feb 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101170464 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1478-811X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221478811X%22">1478811X </searchLink><i>NLM ISO Abbreviation: </i>Cell Commun Signal <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41634806 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12964-026-02682-w Languages: – Code: eng Text: English Titles: – TitleFull: Development of a chaperone-mediated protein degrader targeting ERK5 that efficaciously reduces tumor growth. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yang X – PersonEntity: Name: NameFull: Yin W – PersonEntity: Name: NameFull: Xu M – PersonEntity: Name: NameFull: Tusa I – PersonEntity: Name: NameFull: Menconi A – PersonEntity: Name: NameFull: Dai Y – PersonEntity: Name: NameFull: Ding Q – PersonEntity: Name: NameFull: Wang G – PersonEntity: Name: NameFull: Foley KP – PersonEntity: Name: NameFull: Rovida E – PersonEntity: Name: NameFull: Ying W IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 02 Text: 2026 Feb 03 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1478-811X Numbering: – Type: volume Value: 24 – Type: issue Value: 1 Titles: – TitleFull: Cell communication and signaling : CCS Type: main |
| ResultId | 1 |